Beta-blocker Administration for Cardiomyocyte Division
Beta-blocker Administration for Cardiomyocyte Division
Recruiting · NCT04713657 · Registry updated 2025-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Beta-blocker Administration for Cardiomyocyte Division | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, double outlet right ventricle, heart disorder, heart septal defect, tetralogy of fallot, transposition of the great arteries, ventricular septal defect | Recruiting | Phase 1 | 2025-11-18 | NCT04713657 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| Weill Medical College of Cornell University | 276 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| UPMC Children's Hospital of Pittsburgh | Pittsburgh | United States | 70 |
| Weill Cornell Medicine | New York | United States | 122 |